Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00239
|
|||||
Drug Name |
Digitoxin
|
|||||
Synonyms |
5.beta.-Card-20(22)-enolide, 3.beta.,14-dihydroxy-, 3-[tris-(digitoxoside)]; Acedoxin; Asthenthilo; Cardidigin; Cardigin; Cardiolanata; Carditalin; Carditoxin; Coramedan; Cristapurat; Crystalline digitalin; Crystodigin; Crystodigin (TN); De-Tone; Digicor; Digilanid; Digilong; Digimed; Digimerck; Digipural; Digisidin; Digitalin, crystalline; Digitaline (TN); Digitaline cristallisee; Digitaline nativelle; Digitalinum verum; Digitoksim; Digitoksin; Digitophyllin; Digitossina; Digitossina [DCIT]; Digitoxigenin tridigitoxoside; Digitoxigenin-tridigitoxosid; Digitoxigenin-tridigitoxosid [German]; Digitoxin (JP15/USP/INN); Digitoxin [INN:BAN:JAN]; Digitoxina; Digitoxina [INN-Spanish]; Digitoxine; Digitoxine [INN-French]; Digitoxinum; Digitoxinum [INN-Latin]; Digitoxoside; Digitoxosidum; Digitrin; Ditaven; Glucodigin; Inhibits Na+/K+ ATPase; LT00244784; Lanatoxin; Lanostabil; Mono-digitoxid; Mono-digitoxid [German]; Mono-glycocard; Monodigitoxoside; Myodigin; Natigal; Pandigal; Panlanat; Purodigin; Purodigin, crystalline; Purpurid; Tardigal; Tri-digitoxoside; Tri-digitoxoside [German]; Unidigin
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Kidney disorder [ICD11: GB90] | Approved | [1] | |||
Heart failure [ICD11: BD1Z] | Approved | [1] | ||||
Therapeutic Class |
Antiarrhythmic Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C41H64O13
|
|||||
Canonical SMILES |
CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O
|
|||||
InChI |
InChI=1S/C41H64O13/c1-20-36(46)29(42)16-34(49-20)53-38-22(3)51-35(18-31(38)44)54-37-21(2)50-33(17-30(37)43)52-25-8-11-39(4)24(15-25)6-7-28-27(39)9-12-40(5)26(10-13-41(28,40)47)23-14-32(45)48-19-23/h14,20-22,24-31,33-38,42-44,46-47H,6-13,15-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27+,28-,29+,30+,31+,33+,34+,35+,36-,37-,38-,39+,40-,41+/m1/s1
|
|||||
InChIKey |
WDJUZGPOPHTGOT-XUDUSOBPSA-N
|
|||||
CAS Number |
CAS 71-63-6
|
|||||
Pharmaceutical Properties | Molecular Weight | 764.9 | Topological Polar Surface Area | 183 | ||
Heavy Atom Count | 54 | Rotatable Bond Count | 7 | |||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 13 | |||
XLogP |
2.3
|
|||||
PubChem CID | ||||||
PubChem SID |
10298760
, 103556970
, 104624909
, 11533060
, 12015761
, 124573763
, 127284350
, 127284351
, 127303961
, 127303962
, 127303963
, 127303964
, 127303965
, 127303966
, 127303967
, 127303968
, 127303969
, 127303970
, 134337444
, 134972304
, 135377837
, 135756584
, 137004198
, 14889043
, 16335905
, 24434759
, 24893976
, 26754429
, 29204037
, 3139545
, 36885098
, 46506035
, 47349645
, 48169692
, 48318721
, 48394206
, 48415893
, 48496158
, 50109842
, 50333813
, 53787897
, 57287891
, 57403584
, 7847363
, 7979082
, 85300744
, 85842716
, 87567202
, 9170
, 92298457
|
|||||
ChEBI ID |
ChEBI:28544
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Digitoxin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients. Eur J Clin Pharmacol. 2008 Apr;64(4):367-72. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.